| 7.11 Data as of May 21 |  -0.01 / -0.14%Today’s Change | 6.65 Today|||52-Week Range 10.63 | -6.94% Year-to-Date |
| Previous close | 7.12 |
| Today’s open | 7.10 |
| Day’s range | 6.97 - 7.14 |
| Volume | 36,954 |
| Average volume (3 months) | 69,084 |
| Market cap | $189.6M |
| Dividend yield | -- |
| Earnings growth (last year) | -261.47% |
| Earnings growth (this year) | +68.45% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 2.98 |
| Today’s change | Today’s % change | |
|---|---|---|
| ACSTAcasti Pharma Inc | +0.06 | +2.30% |
| SUPNSupernus Pharmaceuti... | +0.04 | +0.64% |
| CTIXCellceutix Corp | -0.03 | -1.47% |
| VNDAVanda Pharmaceutical... | +0.15 | +2.16% |
| Next reporting date | September 3, 2013 |
| EPS forecast (this quarter) | -$0.56 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$62.5M |
| Net profit margin | -- |
Sector Health Technology |
Industry Pharmaceuticals: Other |
President, Chief Executive Officer & Director Paul R. Edick |
COO, CFO, Secretary & Treasurer Corey N. Fishman |
Corporate headquarters Chicago, Illinois |
.
